Okadaic acid mediates tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel

Molecular Brain Research

Volumn 117, Issue 2, 2003, Pages 145-151

  Ekinci, Fatma J ^a,b   Ortiz, Daniela ^a   Shea, Thomas B ^a  

^a University of Massachusetts Lowell   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Calcium; L voltage calcium channel; MAP kinase; Neurodegeneration; Okadaic acid; Phosphatase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIBODY; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NIMODIPINE; OKADAIC ACID; PHF 1 ANTIBODY; PHOSPHATASE INHIBITOR; TAU PROTEIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ALZHEIMER DISEASE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NEUROBLASTOMA CELL; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANTIBODIES, MONOCLONAL; ANTIGENS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; DENSITOMETRY; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FLAVONOIDS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SPACE; NEUROBLASTOMA; NIMODIPINE; NUCLEAR PROTEINS; OKADAIC ACID; PHOSPHORYLATION; PROTEIN SUBUNITS; SIRTUINS; TAU PROTEINS; TUMOR CELLS, CULTURED;

EID: 1642353487     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00294-8     Document Type: Article

References (48)

1. Amaral M.C., Casillas A.M., Nel A.E. Contrasting effects of two tumour promoters, phorbol myristate acetate and okadaic acid, on T-cell responses and activation of p42 MAP-kinase/ERK-2. Immunology. 79:1993;24-31.
2. Arias C., Becerra-Garcia F., Arrieta I., Tapia R. The protein phosphatase inhibitor okadaic acid induces heat shock protein expression and neurodegeneration in rat hippocampus in vivo. Exp. Neurol. 53:1993;242-254.
3. Baudier J., Cole R.D. Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J. Biol. Chem. 262:1987;17577-17583.
4. Billingsley M.L., Ellis C., Kincaid R.L., Martin J., Schmidt M.L., Lee V.M., Trojanowski J.Q. Calcineurin immunoreactivity in Alzheimer's disease. Exp. Neurol. 126:1994;178-184.
5. Chan W.K.-H., Yabe J.T., Pimenta A.F., Shea T.B. Growth cones contain a highly-dynamic population of neurofilament subunits. Cell Motil. Cytoskel. 54:2002;195-207.
6. Cressman C.M., Shea T.B. Hyperphosphorylation of tau and filopodial retraction following microinjection of protein kinase C catalytic subunits. J. Neurosci. Res. 42:1995;648-656.
7. Drewes G., Mandelkow E.M., Baumann K., Goris J., Merlevede W., Mandelkow E. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A. FEBS Lett. 336:1993;425-432.
8. Drewes G., Lichtenberg-Kraag B., Doring F., Mandelkow E.M., Biernat J., Goris J., Doree M., Mandelkow E. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11:1992;2131-2138.
9. Ekinci F.J., Shea T.B. Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: Additive and synergistic influence of alteration of additional kinase activities. Cell. Mol. Neurobiol. 19:1999;249-260.
10. Ekinci F.J., Malik K.M., Shea T.B. β-Amyloid induces calcium influx and neurodegeneration by MAP kinase-mediated activation of the L voltage-sensitive calcium channel. J. Biol. Chem. 274:1999;30322-30327.
11. Ferrier A., Lu Q., Orecchio L., Kosik K.S. Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar Abeta. Mol. Cell. Neurosci. 9:1997;220-234.
12. Forman M.S., Lee V.M.-Y., Trojanowski J.Q. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies. J. Chem. Anat. 20:2000;225-244.
13. Frace A.M., Hartzell H.C. Opposite effects of phosphatase inhibitors on L-type calcium and delayed rectifier currents in frog cardiac myocytes. J. Physiol. 472:1993;305-326.
14. Gong C.X., Shaikh S., Wang J.Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J. Neurochem. 65:(2):1995;732-738.
15. Gong C.X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem. 275:(8):2000;5535-5544.
16. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA. 83:(13):1986;4913-4917.
17. Haby C., Larsson O., Islam M.S., Aunis D., Berggren P.O., Zwiller J. Inhibition of serine/threonine protein phosphatases promotes opening of voltage-activated L-type Ca2+ channels in insulin-secreting cells. Biochem. J. 298:1994;341-346.
18. Hall G.F. PHF-tau from Alzheimer brain is rapidly dephosphorylated and degraded when injected into neurons in situ. J. Alzheimer's Dis. 1:1999;379-386.
19. Hall G.F., Yao J. Neuronal morphology, axonal integrity and axonal regeneration in situ are regulated by cytoskeletal phosphorylation in identified lamprey central neurons. Microsc. Res. Tech. 48:2000;32-46H.
20. Harris K.A., Oyler G.A., Doolittle G.M., Vincent I., Lehman R.A., Kincaid R.L., Billingsley M.L. Okadaic acid induces hyperphosphorylated forms of tau protein in human brain slices. Ann. Neurol. 33:1993;77-87.
21. Hong M., Chen D.C., Klein P.S., Lee V.M. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 272:1997;25326-25332.
22. Keyse S.M. The role of protein phosphatases in the regulation of mitogen and stress-activated protein kinases. Free Radic. Res. 31:1993;341-349.
23. Kobayashi S., Ishiguro K., Omori A., Takamatsu M., Arioka M., Imahora K., Uchida T. A cdc-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed kinase associated with microtubules. FEBS Lett. 335:1993;171-175.
24. Ladner C.J., Czech J., Maurice J., Lorens S.A., Lee J.M. Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes. J. Neuropathol. Exp. Neurol. 55:1996;924-931.
25. Latimer D.A., Gallo J.M., Lovestone S., Miller C.C., Reynolds C.H., Marquardt B., Stabel S., Woodgett J.R., Anderton B.H. Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau. FEBS Lett. 365:(1):1995;42-46.
26. Lian Q., Ladner C.J., Magnuson D., Lee J.M. Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex. Exp. Neurol. 167:2001;158-165.
27. Lovestone S., Reynolds C.H., Latimer D., Davis D.R., Anderton B.H., Gallo J.M., Hanger D., Mulot S., Marquardt B., Stabel S. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3β in transfected mammalian cells. Curr. Biol. 4:1994;1077-1086.
28. Lu Q., Soria J.P., Wood J.G. p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons. J. Neurosci. Res. 35:1993;439-444.
29. Lu C., Chan S.L., Fu W., Mattson M.P. The lipid peroxidation product 4-hydroxynonenal facilitates opening of voltage-dependent Ca2+ channels in neurons by increasing protein tyrosine phosphorylation. J. Biol. Chem. 277:2002;24368-24375.
30. Matsuo E.S., Shin R.W., Billingsley M.L., Van deVoorde A., O'Connor M., Trojanowski J.Q., Lee V.M. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 13:1994;989-1002.
31. Munoz-Montano J.R., Moreno F.J., Avila J., Diaz-Nido J. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett. 411:1995;183-188.
32. Norris C.M., Blalock E.M., Chen K.C., Porter N.M., Landfield P.W. Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture. Neuroscience. 110:2002;213-225.
33. Obara K., Yabu H. Dual effect of phosphatase inhibitors on calcium channels in intestinal smooth muscle cells. Am. J. Physiol. 264:1993;296-301.
34. Pang L., Sawada T., Decker S.J., Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13585-13588.
35. Patzke H., Tsai L.-H. Cdk5 sinks into ALS. Trends Neurosci. 25:2002;8-10.
36. Pyo H., Jou I., Jung S., Hong S., Joe E.H. Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. Neuroreport. 30:1998;871-874.
37. Raghunandan R., Ingram V.M. Hyperphosphorylation of the cytoskeletal protein Tau by the MAP-kinase PK40erk2: regulation by prior phosphorylation with cAMP-dependent protein kinase A. Biochem. Biophys. Res. Commun. 215:1995;1056-1066.
38. Robinson J.P. Handbook of Flow Cytometry Methods. 1993;Wiley-Liss, New York.
39. Sautiere P.E., Caillet-Boudin M.L., Wattez A., Buee-Scherrer V., Delacourte A. Detection of Alzheimer type pathological epitopes on Tau proteins of neuroblastoma cells after treatment with okadaic acid. C. R. Acad. Sci. III. 316:1993;533-535.
40. Shea T.B., Fischer I. Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules. FEBS Lett. 380:1996;63-67.
41. Shea T.B., Didier M. Biphasic effects of phosphatase inhibition on accumulation of tau phospho-isoforms in cultured cerebellar neurons. Neurosci. Res. Commun. 22:1998;39-44.
42. Shea T.B., Spencer M.J., Beermann M.L., Cressman C.M., Nixon R.A. Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: Involvement of calpain-mediated hydrolysis of protein kinase C. J. Neurochem. 66:1996;1539-1549.
43. Trojanowski J.Q., Lee V.M. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases. FASEB J. 9:1995;1570-1576.
44. Ueda K., Shinohara S., Yagami T., Asakura K., Kawasaki K. Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals. J. Neurochem. 68:1997;265-271.
45. Ueda K., Masliah E., Saitoh T., Bakalis S.L., Scoble H., Kosik K.S. Alz-50 recognizes a phosphorylated epitope of tau protein. J. Neurosci. 10:1990;3295-3304.
46. A. Vandecandelaere, S.R. Martin, M.J. Schilstra, P.M. Bayley, Effects of the tubulin-colchicine complex on microtubule dynamic instability. 33 (1994) 2792-2801.
47. Wang J.Z., Gong C.X., Zaidi T., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J. Biol. Chem. 270:1995;4854-4860.
48. Wiechen K., Yue D.T., Herzig S. Two distinct functional effects of protein phosphatase inhibitors on guinea-pig cardiac L-type Ca2+ channels. J. Physiol. 484:1995;583-592.